Transgenic Model Evaluation II (Acesulfame Potassium): Target Organs and Levels of Evidence for GMM-02
Toxicity Studies of Acesulfame Potassium (CASRN 55589-62-3) in FVB/N-TgN(v-Ha-ras)Led (Tg.AC) Hemizygous Mice and Carcinogenicity Studies of Acesulfame Potassium in B6.129-Trp53tm1Brd (N5) Haploinsufficient Mice (Feed Studies)
| Chemical (Study Title) CASRN | Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|
| Transgenic model evaluation II (Acesulfame potassium) 55589-62-3 | 05/22/2003 | Dosed-Feed 0, 0.3, 1, or 3%; 15/sex/species/dose | BioReliance, Inc |
| Male p53 Haploinsufficient Mice | Female p53 Haploinsufficient Mice | |
|---|---|---|
| 39 Weeks | 39 Weeks | |
| Levels of Evidence | No Evidence | No Evidence |
| Neoplastic Lesions | None | None |
| Non-Neoplastic Lesions | None | None |